Timothy Goggin

Timothy Goggin

Otsuka Pharmaceutical Co. Ltd. - Tokyo / Japan
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4971064
大塚製薬株式会社 大塚製薬株式会社
person_outline Timothy Goggin's MOST POPULAR ARTICLES
1-) Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromesRF Storey, KG Oldroyd, RG WilcoxThrombosis and haemostasis 85 (03), 401-407, 20012592001
2-) Withdrawal of anticonvulsant drugs in patients free of seizures for two yearsN Callaghan, A Garrett, T GogginNew England Journal of Medicine 318 (15), 942-946, 19882561988
3-) A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.N Callaghan, RA Kenny, B O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Neill, M Crowley, T GogginJournal of Neurology, Neurosurgery & Psychiatry 48 (7), 639-644, 19852461985
4-) Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolitesC Twelves, R Glynne-Jones, J Cassidy, J Schüller, T Goggin, B Roos, ...Clinical cancer research 5 (7), 1696-1702, 19991971999
5-) A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsyH Gough, T Goggin, A Bissessar, M Baker, M Crowley, N CallaghanQJM: An International Journal of Medicine 59 (3), 569-577, 19861971986